Trends in management and outcomes of ST-elevation myocardial infarction in patients with end-stage renal disease in the United States.

[1]  Tanush Gupta,et al.  Management and outcomes of ST-elevation myocardial infarction in nursing home versus community-dwelling older patients: a propensity matched study. , 2014, Journal of the American Medical Directors Association.

[2]  D. Kolte,et al.  Trends in Incidence, Management, and Outcomes of Cardiogenic Shock Complicating ST‐Elevation Myocardial Infarction in the United States , 2014, Journal of the American Heart Association.

[3]  D. Kolte,et al.  ST-elevation myocardial infarction in the elderly--temporal trends in incidence, utilization of percutaneous coronary intervention and outcomes in the United States. , 2013, International journal of cardiology.

[4]  G. Kumar,et al.  Pulmonary embolism in patients with CKD and ESRD. , 2012, Clinical journal of the American Society of Nephrology : CJASN.

[5]  Deepak L. Bhatt,et al.  Quality of Care and Outcomes Among Patients With Acute Myocardial Infarction by Level of Kidney Function at Admission: Report From the Get With The Guidelines Coronary Artery Disease Program , 2012, Clinical cardiology.

[6]  A. Folsom,et al.  Twenty-Two–Year Trends in Incidence of Myocardial Infarction, Coronary Heart Disease Mortality, and Case Fatality in 4 US Communities, 1987–2008 , 2012, Circulation.

[7]  Jorge Yarzebski,et al.  Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. , 2010, The American journal of medicine.

[8]  Alan S. Go,et al.  Population trends in the incidence and outcomes of acute myocardial infarction. , 2010, The New England journal of medicine.

[9]  K. Alexander,et al.  Use of Evidence-Based Therapies in Short-Term Outcomes of ST-Segment Elevation Myocardial Infarction and Non–ST-Segment Elevation Myocardial Infarction in Patients With Chronic Kidney Disease: A Report From the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network R , 2010, Circulation.

[10]  M. Movahed,et al.  Rate of acute ST-elevation myocardial infarction in the United States from 1988 to 2004 (from the Nationwide Inpatient Sample). , 2009, The American journal of cardiology.

[11]  J. Ornato,et al.  Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. , 2008, American heart journal.

[12]  J. Panza,et al.  Patients with end-stage renal disease and acute myocardial infarction have poor short-term outcomes despite modern cardiac intensive care , 2008, Coronary artery disease.

[13]  M. Radford,et al.  Impact of the New York State Cardiac Surgery and Percutaneous Coronary Intervention Reporting System on the management of patients with acute myocardial infarction complicated by cardiogenic shock. , 2008, American heart journal.

[14]  M. Blaney,et al.  Clinical Characteristics of Dialysis Patients With Acute Myocardial Infarction in the United States: A Collaborative Project of the United States Renal Data System and the National Registry of Myocardial Infarction , 2007, Circulation.

[15]  K. Eagle,et al.  Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. , 2007, JAMA.

[16]  R. Garrick,et al.  Chronic Renal Dysfunction as an Independent Risk Factor for the Development of Cardiovascular Disease , 2005, Cardiology in review.

[17]  G. Luca,et al.  Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty☆ , 2004 .

[18]  J. Ottervanger,et al.  Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. , 2004, European heart journal.

[19]  J. J. Griffin,et al.  Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction , 2003, Circulation.

[20]  H. Krumholz,et al.  Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[21]  J. Boura,et al.  Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials , 2003, The Lancet.

[22]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[23]  J. Yee,et al.  Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[24]  B. McNeil,et al.  Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  A. Collins,et al.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.

[26]  R. Gibbons,et al.  Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction : A quantitative review , 1997 .

[27]  B. Steinwald,et al.  Hospital case-mix change: sicker patients or DRG creep? , 1989, Health affairs.

[28]  A. Budaj,et al.  Reperfusion in patients with renal dysfunction after presentation with ST-segment elevation or left bundle branch block: GRACE (Global Registry of Acute Coronary Events). , 2009, JACC. Cardiovascular interventions.

[29]  C. Steiner,et al.  Comorbidity measures for use with administrative data. , 1998, Medical care.